183 related articles for article (PubMed ID: 16292352)
1. Intracellular trafficking of retroviral vectors: obstacles and advances.
Anderson JL; Hope TJ
Gene Ther; 2005 Dec; 12(23):1667-78. PubMed ID: 16292352
[TBL] [Abstract][Full Text] [Related]
2. Retroviral vectors for liver-directed gene therapy.
Kalpana GV
Semin Liver Dis; 1999; 19(1):27-37. PubMed ID: 10349681
[TBL] [Abstract][Full Text] [Related]
3. Retroviral vectors for gene therapy of AIDS and cancer.
Chang LJ; He J
Curr Opin Mol Ther; 2001 Oct; 3(5):468-75. PubMed ID: 11699891
[TBL] [Abstract][Full Text] [Related]
4. Retroviral vector targeting for gene therapy.
Günzburg WH; Fleuchaus A; Saller R; Salmons B
Cytokines Mol Ther; 1996 Sep; 2(3):177-84. PubMed ID: 9384702
[TBL] [Abstract][Full Text] [Related]
5. Design of retroviral vectors and helper cells for gene therapy.
Hu WS; Pathak VK
Pharmacol Rev; 2000 Dec; 52(4):493-511. PubMed ID: 11121508
[TBL] [Abstract][Full Text] [Related]
6. [Retroviral vectors in gene therapy].
Prasolov VS; Ivanov DS
Vopr Med Khim; 2000; 46(3):207-25. PubMed ID: 11033882
[TBL] [Abstract][Full Text] [Related]
7. A heterologous system for assembly of retroviral gene vectors: intracellular budding in yeast?
Tolmachov O
Med Hypotheses; 2006; 67(4):807-9. PubMed ID: 16759811
[TBL] [Abstract][Full Text] [Related]
8. Surface-engineering of lentiviral vectors.
Verhoeyen E; Cosset FL
J Gene Med; 2004 Feb; 6 Suppl 1():S83-94. PubMed ID: 14978753
[TBL] [Abstract][Full Text] [Related]
9. Downstream processing of oncoretroviral and lentiviral gene therapy vectors.
Segura MM; Kamen A; Garnier A
Biotechnol Adv; 2006; 24(3):321-37. PubMed ID: 16448798
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
Sinn PL; Sauter SL; McCray PB
Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340
[TBL] [Abstract][Full Text] [Related]
11. Modifying the host range properties of retroviral vectors.
Russell SJ; Cosset FL
J Gene Med; 1999; 1(5):300-11. PubMed ID: 10738547
[TBL] [Abstract][Full Text] [Related]
12. Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways.
Goff SP
J Gene Med; 2001; 3(6):517-28. PubMed ID: 11778899
[TBL] [Abstract][Full Text] [Related]
13. Toolbox for retrovectorologists.
Pagès JC; Bru T
J Gene Med; 2004 Feb; 6 Suppl 1():S67-82. PubMed ID: 14978752
[TBL] [Abstract][Full Text] [Related]
14. Retrovirus vectors: toward the plentivirus?
Baum C; Schambach A; Bohne J; Galla M
Mol Ther; 2006 Jun; 13(6):1050-63. PubMed ID: 16632409
[TBL] [Abstract][Full Text] [Related]
15. Safety features of retroviral vectors.
Hansen AC; Pedersen FS
Curr Opin Mol Ther; 2002 Aug; 4(4):324-33. PubMed ID: 12222870
[TBL] [Abstract][Full Text] [Related]
16. Differential internalization and nuclear uncoating of self-complementary adeno-associated virus pseudotype vectors as determinants of cardiac cell transduction.
Sipo I; Fechner H; Pinkert S; Suckau L; Wang X; Weger S; Poller W
Gene Ther; 2007 Sep; 14(18):1319-29. PubMed ID: 17611587
[TBL] [Abstract][Full Text] [Related]
17. Towards efficient cell targeting by recombinant retroviruses.
Marin M; Noël D; Piechaczyk M
Mol Med Today; 1997 Sep; 3(9):396-403. PubMed ID: 9302690
[TBL] [Abstract][Full Text] [Related]
18. Retroviral vectors for gene therapy.
Guntaka RV; Swamynathan SK
Indian J Exp Biol; 1998 Jun; 36(6):539-45. PubMed ID: 9731465
[TBL] [Abstract][Full Text] [Related]
19. Effects of cell cycle status on early events in retroviral replication.
Katz RA; Greger JG; Skalka AM
J Cell Biochem; 2005 Apr; 94(5):880-9. PubMed ID: 15669021
[TBL] [Abstract][Full Text] [Related]
20. Murine and HIV-based retroviral vectors for in vitro and in vivo gene transfer.
Alfa RW; Blesch A
Methods Mol Med; 2006; 129():241-54. PubMed ID: 17085815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]